pmc logo imageJournal ListSearchpmc logo image
Logo of pursigspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
Other Issues:  previous | next | latest | archive
Volume 3(1);  March 2007
Editorial
Purinergic signalling in the immune system. A brief update
Francesco Di Virgilio
Purinergic Signal. 2007 March; 3(1): 1–3. Published online 2007 February 6. doi: 10.1007/s11302-006-9048-5.
PMCID: PMC2096765
Original Papers
Chemotactic activity of extracellular nucleotideson human immune cells.
Daniel Myrtek and Marco Idzko
Purinergic Signal. 2007 March; 3(1): 5–11. Published online 2007 March 8. doi: 10.1007/s11302-006-9032-0.
PMCID: PMC2096771
Nucleotide receptor signalling and the generation of reactive oxygen species
Alma N. Guerra, Monica L. Gavala, Hun Sun Chung, and Paul J. Bertics
Purinergic Signal. 2007 March; 3(1): 39–51. Published online 2007 January 6. doi: 10.1007/s11302-006-9035-x.
PMCID: PMC2096761
P2 receptors in macrophage fusion and osteoclast formation
Thomas H. Steinberg and Jeffrey F. Hiken
Purinergic Signal. 2007 March; 3(1): 53–57. Published online 2007 February 6. doi: 10.1007/s11302-006-9036-9.
PMCID: PMC2096767
The role of released ATP in killing Candida albicans and other extracellular microbial pathogens by cationic peptides
Slavena Vylkova, Jianing N. Sun, and Mira Edgerton
Purinergic Signal. 2007 March; 3(1): 91–97. Published online 2007 February 8. doi: 10.1007/s11302-006-9040-0.
PMCID: PMC2096768
Adenosine and lymphocyte regulation
Stefania Gessi, Katia Varani, Stefania Merighi, Eleonora Fogli, Valeria Sacchetto, Annalisa Benini, Edward Leung, Stephen Mac-Lennan, and Pier Andrea Borea
Purinergic Signal. 2007 March; 3(1): 109–116. Published online 2007 January 16. doi: 10.1007/s11302-006-9042-y.
PMCID: PMC2096755
From “Hellstrom Paradox” to anti-adenosinergic cancer immunotherapy
Dmitriy Lukashev, Michail Sitkovsky, and Akio Ohta
Purinergic Signal. 2007 March; 3(1): 129–134. Published online 2007 January 24. doi: 10.1007/s11302-006-9044-9.
PMCID: PMC2096757
Adenosine in inflammatory joint diseases
E. S.L. Chan, P. Fernandez, and B. N. Cronstein
Purinergic Signal. 2007 March; 3(1): 145–152. Published online 2007 January 3. doi: 10.1007/s11302-006-9046-7.
PMCID: PMC2096754
P2 receptors in atherosclerosis and postangioplasty restenosis
Cheikh I. Seye, Qiongman Kong, Ningpu Yu, Fernando A. Gonzalez, Laurie Erb, and Gary A. Weisman
Purinergic Signal. 2007 March; 3(1): 153–162. Published online 2007 February 28. doi: 10.1007/s11302-006-9047-6.
PMCID: PMC2096770
CD39 and control of cellular immune responses
Karen M. Dwyer, Silvia Deaglio, Wenda Gao, David Friedman, Terry B. Strom, and Simon C. Robson
Purinergic Signal. 2007 March; 3(1): 171–180. Published online 2007 February 6. doi: 10.1007/s11302-006-9050-y.
PMCID: PMC2096766
Reviews
P1 receptors and cytokine secretion
Maria P. Abbracchio and Stefania Ceruti
Purinergic Signal. 2007 March; 3(1): 13–25. Published online 2007 January 30. doi: 10.1007/s11302-006-9033-z.
PMCID: PMC2096764
P2 purinergic receptor modulation of cytokine production
Christopher A. Gabel
Purinergic Signal. 2007 March; 3(1): 27–38. Published online 2007 January 3. doi: 10.1007/s11302-006-9034-y.
PMCID: PMC2096759
Activation of transcription factors by extracellular nucleotides in immune and related cell types
Souzan Armstrong, Jasminka Korcok, Stephen M. Sims, and S. Jeffrey Dixon
Purinergic Signal. 2007 March; 3(1): 59–69. Published online 2007 January 3. doi: 10.1007/s11302-006-9037-8.
PMCID: PMC2096760
Extracellular NAD and ATP: Partners in immune cell modulation
Friedrich Haag, Sahil Adriouch, Anette Braß, Caroline Jung, Sina Möller, Felix Scheuplein, Peter Bannas, Michel Seman, and Friedrich Koch-Nolte
Purinergic Signal. 2007 March; 3(1): 71–81. Published online 2007 January 9. doi: 10.1007/s11302-006-9038-7.
PMCID: PMC2096762
The role of P2 receptors in controlling infections by intracellular pathogens
Robson Coutinho-Silva, Cristiane Monteiro da Cruz, Pedro M. Persechini, and David M. Ojcius
Purinergic Signal. 2007 March; 3(1): 83–90. Published online 2007 January 12. doi: 10.1007/s11302-006-9039-6.
PMCID: PMC2096763
Purinergic modulation of microglial cell activation
Beáta Sperlágh and Peter Illes
Purinergic Signal. 2007 March; 3(1): 117–127. Published online 2006 December 19. doi: 10.1007/s11302-006-9043-x.
PMCID: PMC2096753
P2 receptors and chronic pain
Kazuhide Inoue
Purinergic Signal. 2007 March; 3(1): 135–144. Published online 2007 January 19. doi: 10.1007/s11302-006-9045-8.
PMCID: PMC2096756
The role of P2X7 in pain and inflammation
Jane P Hughes, Jonathan P Hatcher, and Iain P Chessell
Purinergic Signal. 2007 March; 3(1): 163–169. Published online 2007 January 3. doi: 10.1007/s11302-006-9031-1.
PMCID: PMC2096758
Article
Shaping immune responses through the activation of dendritic cells’ P2 receptors
Davide Ferrari, Stefania Gorini, Giulia Callegari, and Andrea la Sala
Purinergic Signal. 2007 March; 3(1): 99–107. Published online 2006 August 12. doi: 10.1007/s11302-006-9024-0.
PMCID: PMC2096769
Erratum
Molecular modelling study of 2-phenylethynyladenosine (PEAdo) derivatives as highly selective A3 adenosine receptor ligands
Diego Dal Ben, Catia Lambertucci, Sara Taffi, Sauro Vittori, Rosaria Volpini, Karl-Norbert Klotz, and Gloria Cristalli
Purinergic Signal. 2007 March; 3(1): 181. Published online 2006 October 4. doi: 10.1007/s11302-006-9025-z.
PMCID: PMC2096752
Corrects: Diego Dal Ben, et al. Molecular modelling study of 2-phenylethynyladenosine (PEAdo) derivatives as highly selective A3 adenosine receptor ligands. Purinergic Signal. 2006 November; 2(4): 589–594.
Other Issues:  previous | next | latest | archive
Articles from Purinergic Signalling are provided here courtesy of
Springer